TSPEAR and breast cancer: In the present research, knocked down TSPEAR-AS2 repressed GLUT1 and aerobic glycolysis, resulting in lower glucose utilization, ECAR, and the production of lactate and ATP, demonstrating the important part in GLUT1 in aerobic glycolysis and multidrug resistance in BC.